erlotinib hydrochloride has been researched along with Hemorrhage in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Elhag, D; Ferguson, NN; Hammel, JA | 1 |
| Buhl, R; Fischer, B; Makowski, J; Meier, S; Post, F; Schad, A; Schadmand-Fischer, S; Sebastian, M; Springer, E; Taube, C; Wiewrodt, R | 1 |
| Herbst, R; Sandler, A; Vokes, E | 1 |
1 review(s) available for erlotinib hydrochloride and Hemorrhage
| Article | Year |
|---|---|
Angiogenesis inhibition in the treatment of lung cancer.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Disease-Free Survival; Erlotinib Hydrochloride; Hemorrhage; Humans; Lung Neoplasms; Neovascularization, Pathologic; Paclitaxel; Protein Kinase Inhibitors; Quinazolines; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Vascular Endothelial Growth Factor A | 2006 |
2 other study(ies) available for erlotinib hydrochloride and Hemorrhage
| Article | Year |
|---|---|
Subungual hemorrhage from an epidermal growth factor receptor inhibitor.
Topics: ErbB Receptors; Erlotinib Hydrochloride; Hemorrhage; Humans; Male; Middle Aged; Nail Diseases; Protein Kinase Inhibitors | 2020 |
[Hemorrhagic pericardial effusion and multiple pulmonary nodules in a 37 year old male who has "never smoked"].
Topics: Adult; Erlotinib Hydrochloride; Hemorrhage; Humans; Lung Neoplasms; Male; Multiple Pulmonary Nodules; Pericardial Effusion; Protein Kinase Inhibitors; Quinazolines; Smoking; Treatment Outcome | 2009 |